4
Changes in Ownership
Silence Therapeutics plc Filed Acc 0001639860-26-000002
Options or other derivatives
- EVP and Chief R&D Officer acquired 300,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Romano Steven J. EVP and Chief R&D Officer | 2026-01-02 | Grant or award · Employee Share Option (Right to Buy) | +300,000 | 300,000 | D | ||
Loading xslF345X05/form4-01062026_040105.xml…